Staidson(Beijing) Biopharmaceuticals Co.,Ltd. Posted 48.7 Million Yuan Net Loss in First Quarter of 2023

Staidson(Beijing) Biopharmaceuticals Co.,Ltd. (舒泰神(北京)生物制药股份有限公司) (300204.SZ) reported a net loss of 48.7 million yuan in the first quarter of 2023, widening 99.6% year-on-year.

Meanwhile, the company posted 65 million yuan in revenue, down 47.3% year-on-year.

At the end of the reporting period, it had 1.5 billion yuan in total assets and 265.2 million yuan in total liabilities, with a liability-to-asset ratio of 17.2%.